PDLIM7 and nasopharyngeal carcinoma: reported that DZ509, a specific LMP1 targeted DNAzyme, was capable of inhibiting proliferation and inducing apoptosis in C666-1, an EBV positive NPC cell line which constitutively expresses a weak level of LMP1 (128).